MK-4827 - MK4827 - MK 4827 - niraparib hydrochloride - 2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide
pathology | Demonstrated benefit and harm | k | |||
---|---|---|---|---|---|
ovarian cancer | versus No demonstrated result for efficacy | 1 trial | meta-analysis | ||
ovarian cancer | versus placebo No demonstrated result for efficacy | 1 trial | meta-analysis |